Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v2.4.0.8
Consolidated Statements of Changes in Shareholders' Equity (USD $)
In Thousands
Total
Common Shares [Member]
Paid-in Capital in Excess of par Value [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2010 $ 473,996 $ 118 $ 249,902 $ (27,285) $ 251,261
Issuance of 3.7 million, 2.1 million and 0.4 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2011, 2012 and 2013 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012, respectively 26,467 4 26,463    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 26,241   26,241    
Additional capital from share based compensation 24,133   24,133    
Repurchases of 6.0 million, 11.5 million and 6.2 million common shares in 2011, 2012 and 2013, respectively (321,639) (6) (35,427)   (286,206)
Dividends and dividend equivalents ($0.73 per share, $1.20 per share and $1.20 per share) in 2011, 2012 and 2013, respectively (85,489)   638   (86,127)
Net income 414,959       414,959
Foreign currency translation adjustment, net of income taxes of ($3,090), $283 and $(4,309) in 2011, 2012 and 2013, respectively (16,757)     (16,757)  
Unrealized gain (loss) on derivatives, net of income taxes of $1,455, ($1,161) and $1,700 in 2011, 2012 and 2013, respectively 6,233     6,233  
Ending Balance at Dec. 31, 2011 548,144 116 291,950 (37,809) 293,887
Issuance of 3.7 million, 2.1 million and 0.4 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2011, 2012 and 2013 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012, respectively 11,264 3 11,261    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 29,684   29,684    
Additional capital from share based compensation 28,133   28,133    
Repurchases of 6.0 million, 11.5 million and 6.2 million common shares in 2011, 2012 and 2013, respectively (556,727) (12) (57,655)   (499,060)
Dividends and dividend equivalents ($0.73 per share, $1.20 per share and $1.20 per share) in 2011, 2012 and 2013, respectively (135,091)   602   (135,693)
Net income 463,962       463,962
Foreign currency translation adjustment, net of income taxes of ($3,090), $283 and $(4,309) in 2011, 2012 and 2013, respectively 9,821     9,821  
Unrealized gain (loss) on derivatives, net of income taxes of $1,455, ($1,161) and $1,700 in 2011, 2012 and 2013, respectively (3,707)     (3,707)  
Ending Balance at Dec. 31, 2012 395,483 107 303,975 (31,695) 123,096
Issuance of 3.7 million, 2.1 million and 0.4 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2011, 2012 and 2013 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012, respectively 975   975    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 15,566   15,566    
Additional capital from share based compensation 29,492   29,492    
Repurchases of 6.0 million, 11.5 million and 6.2 million common shares in 2011, 2012 and 2013, respectively (306,441) (6) (26,532)   (279,903)
Dividends and dividend equivalents ($0.73 per share, $1.20 per share and $1.20 per share) in 2011, 2012 and 2013, respectively (123,055)   384   (123,439)
Net income 527,525       527,525
Foreign currency translation adjustment, net of income taxes of ($3,090), $283 and $(4,309) in 2011, 2012 and 2013, respectively 3,152     3,152  
Unrealized gain (loss) on derivatives, net of income taxes of $1,455, ($1,161) and $1,700 in 2011, 2012 and 2013, respectively 8,654     8,654  
Unrealized gain on available-for-sale investments, net of income taxes of $51 95     95  
Ending Balance at Dec. 31, 2013 $ 551,446 $ 101 $ 323,860 $ (19,794) $ 247,279